Hostname: page-component-7c8c6479df-ws8qp Total loading time: 0 Render date: 2024-03-28T19:02:21.665Z Has data issue: false hasContentIssue false

The Jenner bicentenary; still uses for smallpox vaccine

Published online by Cambridge University Press:  15 May 2009

Derrick Baxby
Affiliation:
Department of Medical Microbiology, University of Liverpool, Liverpool L69 3BX, UK
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © Cambridge University Press 1996

References

REFERENCES

1.Jenner, E. An inquiry into the causes and effects of the variolae vaccinae. London: Sampson Low, 1798.Google Scholar
2.Baxby, D. The genesis of Edward Jenner's Inquiry of 1798; a comparison of the two unpublished manuscripts and the published version. Med Hist 1985; 29 193–9.CrossRefGoogle ScholarPubMed
3.The Jenner centenary number. BMJ 1896; i: 1245–312.Google Scholar
4.Plotkin, S, Fantini, B, eds. Vaccinia, vaccination, vaccinology: Jenner, Pasteur, and their successors. Paris: Elsevier, 1996.Google Scholar
5.Pastoret, PP, Brochier, B. The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies: a link between Jenner and Pasteur. Epidemiol Infect 1996; 116: 235240.CrossRefGoogle ScholarPubMed
6.Limbach, KJ, Paoletti, E. Non-replicating expression vectors: applications in vaccine development and gene therapy. Epidemiol Infect 1996; 116: 241256.CrossRefGoogle ScholarPubMed
7.Baxby, D. Jenner's smallpox vaccine: the riddle of vaccinia virus and its origin. London: Heinemann Educational Books, 1981.Google Scholar
8.Jenner, E. Further observations on the variolae vaccinae. London: Shury, 1799.Google ScholarPubMed
9.Dixon, CW. Smallpox. London: Churchill, 1962.Google Scholar
10.Fenner, F, Henderson, DA, Arita, I, Jezek, Z, Ladnyj, ID. Smallpox and its eradication. Geneva: WHO, 1988.Google Scholar
11.Panicali, D, Paoletti, E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus DNA into the DNA of infectious vaccinia virus. Proc Soc Natl Acad Sci USA 1982; 79: 7415–9.CrossRefGoogle ScholarPubMed
12.Binns, M, Smith, GL, eds. Recombinant poxviruses. Boca Raton: CRC Press, 1992.Google Scholar
13.Baxby, D. Recombinant poxvirus vaccines. Rev Med Microbiol 1993; 4: 80–8.CrossRefGoogle Scholar
14.Yilma, T, Hsu, D, Jones, L et al. , Protection of cattle against rinderpest with infectious vaccinia virus recombinants expressing the HA or F genes. Science 1988; 242: 1058–61.CrossRefGoogle Scholar
15.Baxby, D. Indications for smallpox vaccine: policies still differ. Vaccine 1993; 11: 395–6.CrossRefGoogle ScholarPubMed
16.Baxby, D, Gaskell, RM, Gaskell, CJ, Bennett, M. Ecology of orthopoxviruses and use of recombinant vaccinia vaccines. Lancet 1986; ii: 850–1.CrossRefGoogle Scholar
17.Tartaglia, J, Perkus, M, Taylor, J et al. , NYVAC: a highly attenuated strain of vaccinia virus. Virology 1992; 188: 217–32.CrossRefGoogle ScholarPubMed
18.Esposito, JJ, Sumner, JW, Brown, D et al. , Raccoon poxvirus rabies-glycoprotein oral vaccine for wildlife; further efficacy studies and serosurvey for raccoon poxvirus. In: Brown, F, Chanock, RM, Ginsberg, H, Lerner, RA, eds. Vaccine '92. Cold Spring Harbor; Cold Spring Harbor Press, 1992; 321–9.Google Scholar
19..Romero, CH, Barrett, T, Chamberlin, RW et al. , Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 1994; 204: 425–9.CrossRefGoogle ScholarPubMed
20.Taylor, J, Weinberg, R, Langhett, B, Desmettre, P, Paoletti, E. Recombinant fowlpox virus induces protective immunity in non-avian species. Vaccine 1988; 6: 497503.CrossRefGoogle ScholarPubMed
21.Cadoz, M, Strady, A, Meignier, B et al. , Immunization with canarypox virus expressing rabies glycoprotein. Lancet 1992; 339: 1429–32.CrossRefGoogle ScholarPubMed
22.Baxby, D, Paoletti, E. Potential use of non-replicating vectors as recombinant vaccines. Vaccine 1992; 10: 89.CrossRefGoogle ScholarPubMed